Page 7 - Read Online
P. 7

Zhang et al. Hepatoma Res 2023;9:5                              Hepatoma Research
               DOI: 10.20517/2394-5079.2023.11



               Editorial                                                                     Open Access



               Improve the precise pathological diagnosis of

               intrahepatic cholangiocarcinoma: introduction to
               2022 expert consensus on pathological diagnosis of

               intrahepatic cholangiocarcinoma in China


                                                                                 5
                                                                                                2
                                  2
                                                      4
                                            3
                                                                    5
                        1
               Xin Zhang , Han Wang , Jun Chen , Xia Sheng , Hongqi Zhang , Lihong Zhang , Wenming Cong , Ji Yuan 1
               1
                Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
               2
                Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai 200438, China.
               3
                Department of Pathology, the Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu,
               China.
               4
                Department of Pathology, Minhang Hospital, Fudan University, Shanghai 201100, China.
               5
                Department of Anatomy, Histology and Embryology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
               Correspondence to: Prof. Wenming Cong, Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Naval Medical
               University, 225 Changhai Road, Shanghai 200438, China. E-mail: wmcong@smmu.edu.cn; Prof. Ji Yuan, Department of
               Pathology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China. E-mail: ji.yuan@zs-hospital.sh.cn
               How to cite this article: Zhang X, Wang H, Chen J, Sheng X, Zhang H, Zhang L, Cong W, Yuan J. Improve the precise
               pathological diagnosis of intrahepatic cholangiocarcinoma: introduction to 2022 expert consensus on pathological diagnosis of
               intrahepatic cholangiocarcinoma in China. Hepatoma Res 2023;9:5. https://dx.doi.org/10.20517/2394-5079.2023.11
               Received: 13 Feb 2023  Accepted: 3 Mar 2023  Published: 9 Mar 2023
               Academic Editor: Guang-Wen Cao  Copy Editor: Ying Han  Production Editor:Ying Han


               Intrahepatic cholangiocarcinoma (ICC) is a highly aggressive intrahepatic epithelial neoplasm with biliary
               differentiation. The clinicopathological characteristics of ICC and extrahepatic cholangiocarcinoma are
               significantly different . In the last 10 years, notable progress has been made in the pathological research of
                                 [1]
               ICC, and some of them have been compiled by the 5th edition of the World Health Organization (WHO)
               Classification of Tumors of the Digestive System. However, the diagnostic strategy of ICC in the current
               WHO classification still has something to be further refined for routine practice. In order to standardize the
               pathological diagnosis of ICC and provide an elaborate pathological basis for personalized treatment in the
               clinic, 46 experts in the field of liver tumors, representing seven professional societies/academic groups of
               China, including pathology, surgery, oncology, and basic disciplines, developed the expert consensus on
                                      [2]
               ICC pathological diagnosis .






                           © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                             www.hrjournal.net
   2   3   4   5   6   7   8   9   10   11   12